Global Medical Imaging Industry Quarterly Tracker, Q1 2019

Global Medical Imaging Industry Quarterly Tracker, Q1 2019 Updated Research Available

Quarterly Edition of Trends in Medical Imaging and Informatics Covering Competition, Policy, Regulatory, and Clinical Areas

RELEASE DATE
25-Sep-2019
REGION
North America
Deliverable Type
Market Research
Research Code: MEDA-01-00-00-00
SKU: HC03203-GL-MR_23470
AvailableYesPDF Download

$3,000.00

Special Price $2,250.00 save 25 %

In stock
SKU
HC03203-GL-MR_23470

$3,000.00

$2,250.00save 25 %

DownloadLink
ENQUIRE NOW

Description

The medical imaging and informatics industry is evolving rapidly, and new products and solutions are launched every other day. As the reimbursement environment is transitioning from fee-for-service to value-based payment, vendors’ business models and value propositions are undergoing drastic changes. New evidence regarding the use of certain techniques in imaging is influencing changes in the standard of care. On a macro level, the government's policies on reimbursement and regulations tend to impact the performance of industry participants, if their internal teams delay the calibration of the strategic actions needed to thrive in this new environment.

To help its clients address challenges in an intensely competitive environment, Frost & Sullivan has introduced the Medical Imaging and Informatics Quarterly Insights tracker that will monitor market factors and significant events and qualitatively assess their impact on the industry; this will cover the diagnostic imaging, image-guided therapies, and imaging informatics segments.

Research Scope

The scope of this deliverable covers the following segments:

  • Clinical Trends

   o  Disruptive trends that impact the current ‘gold standard’
   o  Trends that indicate the clinical adoption of new solutions/products
   o  Important announcements from associations such as RSNA, ESR, ACR, and ACC

  • Competition

   o  New product launches and capabilities
   o  Mergers and acquisitions
   o  FDA and CE approvals
   o  Major FDA and CE recalls/warnings

  • Policies and Regulations

   o  Region-specific introduction of new regulatory approvals
   o  Reimbursement achievements or setbacks

  • Event Highlights

   o  Major event highlights in the quarter that cover important themes – this is derived by studying the messaging and communications, product launches, and product promotions at the events

Author: Suresh Kuppuswamy


Table of Contents

Methodology

Scope

Key Takeaways

Competition—Long-term Business Contracts

Competition—Long-term Business Contracts (continued)

Competition—Long-term Business Contracts (continued)

Competition—New Launches

Competition—New Launches (continued)

Competition—New Launches (continued)

Competition—Corporate Highlights

Competition—Corporate Highlights (continued)

Competition—Business Collaboration

FDA Approvals from Top-tier Companies (January–March 2019)

FDA Approvals from Other Companies (January–March 2019)

Notable CE Approvals

FDA Recalls

FDA Recalls (continued)

Policies and Regulations

Policies and Regulations (continued)

Policies and Regulations (continued)

Policies and Regulations (continued)

Policies and Regulations (continued)

Policies and Regulations (continued)

Policies and Regulations (continued)

Clinical Trends

Clinical Trends (continued)

Clinical Trends (continued)

Clinical Trends (continued)

Clinical Trends (continued)

Clinical Trends (continued)

Clinical Trends (continued)

Event Highlights

Event Highlights (continued)

Event Highlights (continued)

Conclusion

Legal Disclaimer

List of Exhibits

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

The medical imaging and informatics industry is evolving rapidly, and new products and solutions are launched every other day. As the reimbursement environment is transitioning from fee-for-service to value-based payment, vendors’ business models and value propositions are undergoing drastic changes. New evidence regarding the use of certain techniques in imaging is influencing changes in the standard of care. On a macro level, the government's policies on reimbursement and regulations tend to impact the performance of industry participants, if their internal teams delay the calibration of the strategic actions needed to thrive in this new environment. To help its clients address challenges in an intensely competitive environment, Frost & Sullivan has introduced the Medical Imaging and Informatics Quarterly Insights tracker that will monitor market factors and significant events and qualitatively assess their impact on the industry; this will cover the diagnostic imaging, image-guided therapies, and imaging informatics segments.--BEGIN PROMO--

Research Scope

The scope of this deliverable covers the following segments:

  • Clinical Trends

   o  Disruptive trends that impact the current ‘gold standard’
   o  Trends that indicate the clinical adoption of new solutions/products
   o  Important announcements from associations such as RSNA, ESR, ACR, and ACC

  • Competition

   o  New product launches and capabilities
   o  Mergers and acquisitions
   o  FDA and CE approvals
   o  Major FDA and CE recalls/warnings

  • Policies and Regulations

   o  Region-specific introduction of new regulatory approvals
   o  Reimbursement achievements or setbacks

  • Event Highlights

   o  Major event highlights in the quarter that cover important themes – this is derived by studying the messaging and communications, product launches, and product promotions at the events

Author: Suresh Kuppuswamy

More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Suresh Kuppuswamy
Industries Healthcare
WIP Number MEDA-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9566-B1,9570-B1,99BE-B1,9614-B1